While treatment for opioid-use disorder remains gender blind, the impact and effects of the disease are not.
Use of state prescription drug monitoring programs has grown significantly, but gaps remain—including a lack of data from VA pharmacies.
The AMA House of Delegates weighs in on emerging drugs of abuse, veterans’ care, and treatment for pain and opioid-use disorder.
While reversing the opioid epidemic remains a vital focus, AMA delegates seek strategies, education to help the millions who live with chronic pain.
The Maryland State Medical Society offers physicians free training in use of the state PDMP and to identify and help patients with opioid-use disorders.